Lonidamine Alone and in Combination with Other Chemotherapeutic Agents in the Treatment of Cancer Patients
- 1 January 1984
- journal article
- clinical trial
- Published by S. Karger AG in Oncology
- Vol. 41 (1) , 108-112
- https://doi.org/10.1159/000225897
Abstract
The tolerance and antitumor activity of Lonidamine administered alone and in combination with other anticancer agents were studied. Myalgia was the most frequent side effect; there were no changes in the hematological parameters attributable to Lonidamine administration. 1 partial response out of the 16 patients treated with Lonidamine alone was observed.Keywords
This publication has 0 references indexed in Scilit: